158 related articles for article (PubMed ID: 34677979)
1. MR/NIRF Dual-Mode Imaging of αvβ3 Integrin-Overexpressing Tumors Using a Lipopeptide-Based Contrast Agent.
Wang Q; Huang L; Zhu X; Zhou Y; Wang J; Su D; Liu L
Mol Pharm; 2021 Dec; 18(12):4543-4552. PubMed ID: 34677979
[TBL] [Abstract][Full Text] [Related]
2. Cy5.5 conjugated MnO nanoparticles for magnetic resonance/near-infrared fluorescence dual-modal imaging of brain gliomas.
Chen N; Shao C; Li S; Wang Z; Qu Y; Gu W; Yu C; Ye L
J Colloid Interface Sci; 2015 Nov; 457():27-34. PubMed ID: 26151564
[TBL] [Abstract][Full Text] [Related]
3. Radiolabeled ultra-small Fe
Sun H; Zhang B; Jiang X; Liu H; Deng S; Li Z; Shi H
Nanomedicine (Lond); 2019 Jan; 14(1):5-17. PubMed ID: 30451578
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.
Anderson CR; Hu X; Zhang H; Tlaxca J; Declèves AE; Houghtaling R; Sharma K; Lawrence M; Ferrara KW; Rychak JJ
Invest Radiol; 2011 Apr; 46(4):215-24. PubMed ID: 21343825
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound and magnetic resonance imaging of cyclic arginine glycine aspartic acid-gadopentetic acid-polylactic acid in human breast cancer by targeting αvβ3 in xenograft-bearing nude mice.
Fu D; Huang X; Lv Z; Zhang Y; Chen M; Zhang W; Su D
Bioengineered; 2022 Mar; 13(3):7105-7117. PubMed ID: 35259049
[TBL] [Abstract][Full Text] [Related]
6. Development of a Squaraine-Based Molecular Probe for Dual-Modal
Park YD; Park JE; Kim HS; Choi SH; Park JE; Jeon J; Park SH
Bioconjug Chem; 2020 Nov; 31(11):2607-2617. PubMed ID: 33108158
[TBL] [Abstract][Full Text] [Related]
7. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model.
Chen WT; Shih TT; Chen RC; Tu SY; Hsieh WY; Yang PC
Mol Imaging; 2012; 11(4):286-300. PubMed ID: 22954145
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and In Vitro Study of a Dual-Mode Probe Targeting Integrin α
Zhang Y; Zhu X; Liu L; Hong S; Zuo Z; Wang P; Su D
Nanoscale Res Lett; 2018 Sep; 13(1):281. PubMed ID: 30203331
[TBL] [Abstract][Full Text] [Related]
9. cRGD-functionalized, DOX-conjugated, and ⁶⁴Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging.
Yang X; Hong H; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Xiao Y; Yang Y; Zhang Y; Nickles RJ; Cai W; Steeber DA; Gong S
Biomaterials; 2011 Jun; 32(17):4151-60. PubMed ID: 21367450
[TBL] [Abstract][Full Text] [Related]
10. Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects.
Song Z; Lin Y; Zhang X; Feng C; Lu Y; Gao Y; Dong C
Int J Nanomedicine; 2017; 12():1941-1958. PubMed ID: 28331317
[TBL] [Abstract][Full Text] [Related]
11. A targeted nanoglobular contrast agent from host-guest self-assembly for MR cancer molecular imaging.
Zhou Z; Han Z; Lu ZR
Biomaterials; 2016 Apr; 85():168-79. PubMed ID: 26874280
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumor cells and neovascularization using RGD-functionalized magnetoliposomes.
Garcia Ribeiro RS; Belderbos S; Danhier P; Gallo J; Manshian BB; Gallez B; Bañobre M; de Cuyper M; Soenen SJ; Gsell W; Himmelreich U
Int J Nanomedicine; 2019; 14():5911-5924. PubMed ID: 31534330
[TBL] [Abstract][Full Text] [Related]
13. Near-infrared optical imaging of integrin alphavbeta3 in human tumor xenografts.
Wang W; Ke S; Wu Q; Charnsangavej C; Gurfinkel M; Gelovani JG; Abbruzzese JL; Sevick-Muraca EM; Li C
Mol Imaging; 2004 Oct; 3(4):343-51. PubMed ID: 15802051
[TBL] [Abstract][Full Text] [Related]
14. RGD-human serum albumin conjugates as efficient tumor targeting probes.
Chen K; Xie J; Chen X
Mol Imaging; 2009; 8(2):65-73. PubMed ID: 19397852
[TBL] [Abstract][Full Text] [Related]
15. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model.
Hsu AR; Hou LC; Veeravagu A; Greve JM; Vogel H; Tse V; Chen X
Mol Imaging Biol; 2006; 8(6):315-23. PubMed ID: 17053862
[TBL] [Abstract][Full Text] [Related]
16. Real-time near-infrared fluorescence imaging using cRGD-ZW800-1 for intraoperative visualization of multiple cancer types.
Handgraaf HJM; Boonstra MC; Prevoo HAJM; Kuil J; Bordo MW; Boogerd LSF; Sibinga Mulder BG; Sier CFM; Vinkenburg-van Slooten ML; Valentijn ARPM; Burggraaf J; van de Velde CJH; Frangioni JV; Vahrmeijer AL
Oncotarget; 2017 Mar; 8(13):21054-21066. PubMed ID: 28416744
[TBL] [Abstract][Full Text] [Related]
17. Theranostic imaging of liver cancer using targeted optical/MRI dual-modal probes.
Chen Q; Shang W; Zeng C; Wang K; Liang X; Chi C; Liang X; Yang J; Fang C; Tian J
Oncotarget; 2017 May; 8(20):32741-32751. PubMed ID: 28416757
[TBL] [Abstract][Full Text] [Related]
18. High expression of integrin αvβ3 enables uptake of targeted fluorescent probes into ovarian cancer cells and tumors.
Shaw SK; Schreiber CL; Roland FM; Battles PM; Brennan SP; Padanilam SJ; Smith BD
Bioorg Med Chem; 2018 May; 26(8):2085-2091. PubMed ID: 29548784
[TBL] [Abstract][Full Text] [Related]
19. MRI contrast agent for targeting glioma: interleukin-13 labeled liposome encapsulating gadolinium-DTPA.
Liu X; Madhankumar AB; Miller PA; Duck KA; Hafenstein S; Rizk E; Slagle-Webb B; Sheehan JM; Connor JR; Yang QX
Neuro Oncol; 2016 May; 18(5):691-9. PubMed ID: 26519740
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
